The landscape of transcriptomic and proteomic studies in sarcoidosis

Maneesh Bhargava, Shu-Yi Liao, Elliott D. Crouser, Lisa A. Maier, Sonia M. Leach

Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maneesh Bhargava, Shu-Yi Liao, Elliott D. Crouser, Lisa A. Maier, Sonia M. Leach. The landscape of transcriptomic and proteomic studies in sarcoidosis. ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes
Source: Eur Respir J 2014; 44: 985-993
Year: 2014

Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018

A comparative proteomic profiling of the human erythrocyte membrane in COPD patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013

Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
Source: ERS Lung Science Conference 2016
Year: 2016

Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Transcriptome profiling reveals the complexity of pirfenidone effects in IPF.
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Integration of transcriptomics and metabolomics with microbiomic data to identify host-microbiota interactions
Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome
Year: 2019

From genomics to proteomics
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008

LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016

Identification of disease genes by expression profiling
Source: Eur Respir J 2001; 18: 882-889
Year: 2001

Metabolomic analyses reveal new stage-specific features of COVID-19
Source: Eur Respir J, 59 (2) 2100284; 10.1183/13993003.00284-2021
Year: 2022

Endotyping bronchiectasis through multi-omic profiling
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020

Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019